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INTRODUCTION
Bacteroides are saccharolytic Gram-negative obligate
anaerobes that are most predominant in the human
colon (1). The representative species of the genus Bac-
teroides is B. fragilis, and ten species that are phyloge-
netically close to B. fragilis have been defined as“B.
fragilis group”(2). The B. fragilis group species are
frequently isolated from mixed aerobic-anaerobic in-
fections such as intra-abdominal, diabetic foot and soft
tissue infections, though their virulence potentials are
different. B. fragilis is regarded as the most virulent
species among Bacteroides species and often causes
severe bacteremia (3, 4). Although the growth rate
of Bacteroides species is faster than that of other ob-
ligate anaerobes, identification of Bacteroides species
by the traditional anaerobic culture method based on
carbohydrate fermentation patterns is laborious, and
use of this procedure sometimes results in misiden-
tification. These conditions often delay the useful ap-
plication of species identification and susceptibility
data for patients. Therefore, PCR-based rapid and ac-
curate identification methods in which specific genes
such as glutamine synthetase gene (5) and neuramini-
dase gene (6, 7) are amplified have been developed for
B. fragilis. Results obtained by using these methods
showed that these methods have sufficient levels of
specificity and sensitivity to be used for clinical speci-
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mens but that they provide limited information when
species other thanB. fragilis are contained in the speci-
mens. A recent study on isolation rates of B. fragilis
group species and antimicrobial susceptibility patterns
demonstrated that the isolation rate has changed in
the past ten years and that the increase in non-B. fragilis
species has influenced the overall antimicrobial sus-
ceptibility of Bacteroides isolates (8). It is therefore im-
portant to develop a rapid and accuratemethod for iden-
tifying non-B. fragilis species for empirical antimicro-
bial therapy used by clinicians for treatment of mixed
aerobic-anaerobic infections.
Theaimof this studywas todevelopaPCR-basedmethod
for the simultaneous detection of all B. fragilis group
species. For this purpose,wechoseβ-isopropylmalate
dehydrogenase gene (leuB), which is involved in leucine
biosynthesis, as a target becauseB. fragilisgroupspecies
are leucine prototrophs and thought to have a complete
set of genes for the leucine biosynthetic pathway (9).
MATERIALS AND METHODS
Bacterial strains
Bacterial strains used in this study are as follows. The
anaerobes usedwere 9 strains ofB. fragilis (2 laboratory
strains, ATCC25285 and ATCC43859, and 7 clinical
isolates), 6 strains each ofB. distasonis (ATCC8503 and
5 clinical isolates) and B. vulgatus(ATCC8482 and 5
clinical isolates), 5 strains ofB. thetaiotaomicron (ATCC
29148 and 4 clinical isolates), 4 strains ofB. uniformis
(2 laboratory strains, ATCC8492 and BU1001, and 2
clinical isolates), 3 strains of B. ovatus (ATCC8483 and
2 clinical isolates), and one strain each ofB. caccae (JCM
9498), B. eggerthii (ATCC27754),B. merdae (JCM9497),
B. stercoris (JCM9496),Porphyromonas gingivalis (381),
Por. asaccharolytica (NCTC9337),Por. endodontalis (ATCC
35406), Prevotella corporis (JCM8480),Prevotella melani-
nogenica (ATCC25845), Clostridium perfringens (GAI
0668), Eubacterium limosum (ATCC8480), and Fuso-
bacterium nucleatum (F-1). The aerobes used in this
studywere one strain each ofBacillus subtilis (T),Staphy-
lococcus aureus (209P), Staphylococcus epidermidis (IID
866), Streptococcus pyogenes (UTB111),Klebsiella pneu-
moniae (KUB13),Enterobacter aerogenes (UTB7),Pro-
teus vulgaris (KUB22), Serratia marcescens (UTB66),
Pseudomonas aeruginosa (UTC55), and Escherichia coli
(W3110). All anaerobic bacteria were cultured onGAM
agar plates (Nissui Pharmaceutical Co., Tokyo, Japan)
under anaerobic conditions. Aerobes except for Strep-
tococcus pyogenes were cultured on Luria-Bertani (LB)
agar plates (10). Streptococcus pyogenes was cultured
on a 5% sheep blood agar plate.
Preparation of bacterial cells for PCR
Several colonies of each strain grown on GAM,
LB, or 5% sheep blood agar plates were suspended in
1.0 ml of TE buffer (10 mM Tris-HCl [pH 8.0], 1 mM
EDTA) and heated at 100℃ for 10 min. After centrifu-
gation at 12,000 g for 1 min, 10 µl of the supernatantwas
collected and used as a template for the PCR ampli-
fication of leuB . The mid-logarithmic phase culture
(1.0 ml) of B. fragilis strain ATCC25285 in GAMbroth
was centrifuged, washed in1.0ml of TE buffer, and
resuspended in 1.0 ml of TE. Serial 10-fold dilutions
were prepared to give appropriate colony forming units
(CFU), and they were lysed by heating at 100℃ for
10 min. The supernatant (10 µl) of each dilution after
centrifugation at 12,000 g for 1 min was used as a tem-
plate to determine the sensitivity of leuB -PCR
PCR amplification and partial sequencing of leuB
genes from B. fragilis group species
Oligonucleotide primers used in this study are listed
in Table 1. Three kinds of primer sets (LBF22-LBR
44, LBF22-LBR55, and BacLBF-BacLBR) were used
for amplification of leuB . PCR amplification of leuB
was performed using 10 µl of heated cell supernatant
of each strain, 0.5 µMof each oligonucleotide primer,
and 2.5 units of AmpliTaq Gold (Perkin-Elmer Co.,
CT, U.S.A.) in the following setting: pre-heating (96℃
for 10 min), 40 cycles of DNA denaturation (96℃ for
Table 1. Oligonucleotide primers used for PCR amplification of leuB .
Primer Sequence (5’ to 3’)＊ Location ＊＊
LBF22
LBR44
LBR55
BacLBF
BacLBR
TGYGARAARTTYGGICA
CCYTCIACYTGIATYTC
ATRTARTCIACIATCCA
TGGCIATGCGYAARAA
CCCATRGARCCRCTGAT
85-101
982-998
1033-1049
281-296
754-770
＊ Y=T or C, R=A or G, and I=inosine.
＊＊ The location in the nucleotide sequence of B. fragilis strain YCH 46 leuB gene (13) is shown.
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1 min)/primer annealing (50℃ for1min)/DNA ex-
tension (72℃ for 1min). PCR products were separated
by 2.0% agarose-gel electrophoresis and visualized
by ethidium bromide staining. The LBF22-LBR 55-
generated leuB products were excised from agarose
gel and purified using a QIA quick gel extraction kit
(QIAGEN, Inc., CA, U.S.A.) according to the manu-
facturer’s instructions. DNA concentration was de-
termined spectrophotometrically, and 200 ng of each
purified product was used for sequencing analysis.
Nucleotide sequences of the internal portions of leuB
genes of B. fragilis group species were determined
on both strands with an automated sequencer (Ge-
netic Analyzer 310, Applied Biosystems Inc., Foster
City, Calif., U.S.A.) usingBigDye terminator chemistry
(Applied Biosystems). Nucleotide sequences obtained
were aligned by using themultiple sequence alignment
program Clustal W (11). The B. fragilis group-specific
regions within leuB were determined by homology
searches of the sequences obtained against public
databases by BLASTN (12).
Isolation of bacteria from rat feces
One piece of fresh rat feces (ca. 0.1 g)was suspended
in anaerobic solution (33 mM KH2PO4, 42 mM Na2
HPO4, 0.05% L-cystein-HCl, 0.05% Tween 80, and 0.1%
agar), and serial 10-fold dilutions were prepared with
the anaerobic solution. A part of each dilution (0.1ml)
was plated on GAMagar plates and incubated anaero-
bically for 48 hrs. Seventy-five colonies were randomly
selected and isolated on freshGAMagar plates.Gram-
staining was performed on all of the isolates, and bio-
´chemical tests using an API 20 A system (BioMerieux
S.A., France) were performed on obligate anaerobes
for species identification.
Nucleotide sequence accession numbers
The partial leuB sequences that we determined in
this study have been assigned the following GenBank
accession numbers : AB196153 (B. caccae strain JCM
9498), AB196154 (B. distasonis strain ATCC8503),
AB196155 (B. eggerthii strain ATCC27754), AB196149
(B. fragilis strain YCH1), AB196148 (B. fragilis strain
ATCC25285), AB196150 (B. fragilis strain YCH46),
AB196152 (B. ovatus strain ATCC8483), AB196151
(B. ovatus strain KYU7), AB196156 (B. stercoris strain
JCM9496), AB196157 (B. thetaiotaomicron strain
ATCC29148), AB196158 (B. thetaiotaomicron strain
KYU12), AB196159 (B. thetaiotaomicron KYU16), AB
196160 (B. uniformis strain ATCC8492), AB196164
(B. uniformis strain BU1001), AB196163 (B. uniformis
strain OMC37), AB196161(B. vulgatus strain ATCC
8482), and AB196162 (B. vulgatus strain KYU10).
RESULTS
Partial sequencing of the leuB genes ofB. fragilisgroup
species
AmongBacteroides species, the nucleotide sequences
Fig. 1. The nucleotide sequence and the deduced amino acid sequence of the leuB gene from B. fragilis strain YCH46(13). The variable
amino acids when compared with B. thetaiotaomicron strain VPI-5482 are circled. The annealing sites of the PCR primers (LBF22, LBR44,
and LBR55) used for amplification of leuB from B. fragilis group species are double-underlined.
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of leuB have been determined in B. fragilis strain YCH
46(13, 14) and B. thetaiotaomicron strain VPI-5482 (15).
The nucleotide sequences of leuB in other B. fragilis
group species must be obtained to design universal
primers for all species in the B. fragilis group. Firstly,
we designed PCR primers to amplify the leuBgene from
B. fragilis group species other than B. fragilis and B.
thetaiotaomicron . The predicted amino acid sequences
of leuB inB. fragilis andB. thetaiotaomicronwerehighly
conserved and showed 94.9% identity. The nucleo-
tide sequence identity was 79.9% and a total of 213mis-
matches were found within a 1,062-bp leuB sequence.
Of those, 172 mismatches (80.8%) were present in the
third position of the codon, and only 15 of them were
responsible for amino acid substitutions. Therefore,
we designed degenerate primers (LBF22, LBR44, and
LBR55) from the conserved regions betweenB. fragilis
and B. thetaiotaomicron, in which amino acids with low
degeneracy are abundant (Fig. 1).
The results of amplification of leuB using the primer
set LBF22-LBR44 or LBF22-LBR55 from type strains
of 10 B. fragilis group species are shown in Table 2.
The primer set LBF22-LBR55 generated the band of
expected size (965 bp) from all of the type strains tested
except for B. merdae strain JCM9497. The other primer
set, LBF22-LBR44, also failed to yield a product from
B. merdae strain JCM9497 despite the fact that both
primer sets were able to generate an expected product
from B. distasonis, which is a species close phyloge-
netically to B. merdae. We then amplified leuB genes
from seventeen strains of nine species in theB. fragilis
group except for B. merdae using the primer set LBF
22-LBR55 and determined the nucleotide sequences
of the products. Overall nucleotide sequence identities
among the strains tested ranged from 77 to 100%.
Design of PCR primers specific for species of the B.
fragilis group
We aligned the partial leuB sequences from seven-
teen strains obtained as described above andsearched
for the conserved region among the species to design
specific and universal primers forB. fragilis group spe-
cies. Degenerate PCR primers, BacLBF and BacLBR,
were synthesized on the basis of nucleotide sequences
at positions 281-296 and 754-770, respectively, to be
used for specific and simultaneous PCR detection of
B. fragilis group species (Table 1 and Fig. 2).
Specificity test of the PCR primer set
To evaluate the specificity of the PCR primer set,
BacLBF-BacLBR, we amplified leuB genes from 52
strains (37strains of the B. fragilis group, 5 strains of
species closely related to the B. fragilis group, and 10
strains of unrelated aerobes) that had been stocked
in our laboratory. As shown in Fig. 3 and Table 3, the
PCR primer set, BacLBF-BacLBR, produced a 490-bp
band from all strains of the B. fragilis group species
tested except for one strain of B. distasonis. In contrast,
none of the other species generated a 490-bp band.
The specificity of BacLBF-BacLBR was further ex-
amined in a blind fashion using 75 isolates from rat
feces (43 aerobes and 32 anaerobes) (Table 4). Al-
though only two B. fragilis group species (B. caccae
and B. vulgatus) were identified within the isolates,
a leuB amplification product was obtained from all
strains of the two species. On the other hand, none
of the other isolates generated any product except for
one Gram-positive rod. This fastidious Gram-positive
isolate was lost during cultivation and could not be
identified at a species level. These results indicated that
the leuB-derected PCR using the primer set, BacLBF-
BacLBR, is a useful diagnostic tool for rapid detection
of medically important B. fragilis group species.
Sensitivity of the PCR
As shown in Fig. 4, we prepared serial 10-fold di-
lutions of the B. fragilis strain ATCC25285, which con-
tained cells from 3.9×10-1 to 3.9×106 CFU and were
used as templates for amplification of leuB with the
primer set BacLBF-BacLBR. The detection limit of
leuB -directed PCR using BacLBF and BacLBR was
3.9×103 CFU.
DISCUSSION
B. fragilis group species are medically important
Gram-negative obligate anaerobes and are often as-
sociated with a variety of human infections. Since local
Bacteroides infection often causes severe bacteremia
in immunocompromised patients and since B. fragilis
group species are the most resistant to antimicrobial
agents among all anaerobes, rapid and accurate dif-
ferentiation of anaerobic isolates is needed for effective
management of infected patients. However, phenotypic
tests for anaerobes by traditional culturemethods used
in clinical laboratories are time-consuming. In ad-
dition, comparisons of the results from 16S rDNA se-
quence based-identification and phenotypic tests re-
vealed that only 45.5% of B. cacacae, 53.3% of B. ovatus,
66.7% of B. merdae, and 78.6% of B. thetaiotaomicron
were correctly identified by phenotypic tests (16). PCR-
based rapid diagnosis has been targeted to B. fragilis
because this species is the most virulent among Bac-
T. Miki et al. Simultaneous PCR detection of Bacteroides１０４
    
 
   
  
    
    
 
 
 
 
  
  
   
   
 
   
   
 
   
 
 
 
 
     
  
 
 
   
 
 
 
  
  
Fig. 2. Alignment of partial leuB sequences of B. fragilis group species. Numbers on both sides indicate the
nucleotide positions in leuB of B. fragilis strain YCH46. The annealing sites of the primers BacLBF and BacLBR
are indicated and double-underlined. Asterisks indicate the conserved nucleotides among all of the strains tested.
Table 2. Results of PCR amplification of leuB from Bacteroides fragilis group species.
Bacterial strain
Primer set used
LBF22-LBR44 LBF22-LBR55
B. caccae JCM9498
B. distasonis ATCC8503
B. eggerthii ATCC27754
B. fragilis ATCC25285
B. merdae JCM9497
B. ovatus ATCC8483
B. stercoris JCM9496
B. thetaiotaomicron ATCC29148
B. uniformis ATCC8492
B. vulgatus ATCC8482
NT
+
NT
NT
―
NT
NT
NT
NT
NT
+
+
+
+
―
+
+
+
+
+
NT, not tested.
Plus and minus indicate whether visible and invisible bands produced by the PCR, respectively.
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teroides and accounts for 63% of all theB. fragilis group
isolates (17). However, a recent survey has revealed
that isolation rates of Bacteroides species other than
B. fragilis have been increasing in the past ten years.
It is therefore important todevelopa rapid andaccurate
technique for identification of all B. fragilis group spe-
cies for appropriate treatment of anaerobic infections.
Liu et al. have recently reported B. fragilis group-
specific PCR primers designed on the basis of the 16S
rDNA sequence (16). However, due to the high se-
quence similarities of 16S rDNA among closely related
species, this primer set also reacts to several strains
of Porphyromonas and Prevotella . In this study, we
synthesized B. fragilis group-specific PCR primers
(BacLBF-BacLBR) on the basis of β-isopropylmalate
dehydrogenase gene. This primer set showed high
specificity forB. fragilis group species and did not cross-
react with closely related species in Porphyromonas
and Prevotella .
The minimum level of leuB -directed PCR using
BacLBF and BacLBR was 3.9×103 cells. It seems to be
difficult to apply leuB-directed PCR for direct detection
of Bacteroides in specimens that contain relatively small
numbers ofbacterial cells, suchas inabloodsample from
a patient with bacteremia. However, the PCR will be a
useful diagnostic tool when it is applied to specimens
that contain relatively large numbers of bacterial cells
such as samples of pus or drainage fluids. It will alsobe
Fig. 3. Specificity of the leuB -directed PCR using BacLBF and BacLBR. Lanes : 1, B. caccae JCM9498 ; 2, B.
distasonis ATCC8503 ; 3, B. eggerthii ATCC27754 ; 4,B. fragilis ATCC25285 ; 5, B. merdae JCM9497 ; 6, B. ovatus
ATCC8483 ; 7, B. stercoris JCM9496 ; 8, B. thetaiotaomicron ATCC29148 ; 9, B. uniformis ATCC8492 ; 10, B. vulgatus
ATCC8482 ; 11, Por. asaccharolytica ATCC25260 ; 12, Por. gingivalis 381 ; 13, Prevotella corporis JCM8529 ;14,
Prevotella melaninogenica ATCC25845 ; 15, Escherichia coli W3110 ; M, molecular size markers.
Table 3. Specificity tests of the oligonucleotide primers, BacLBF and BacLBR, using phenotypically characterized bacterial strains.
Species classification No. of strains
leuB -directed PCR
No. of positive No. of negative
Bacteroides fragilis group
B. caccae
B. distasonis
B. eggerthii
B. fragilis
B. merdae
B. ovatus
B. stercoris
B. thetaiotaomicron
B. uniformis
B. vulgatus
Species closely related to
B. fragilis group
Porphyromonas asaccharolytica
Por. gingivalis
Por. endodontalis
Prevotella corporis
Prevotella melaninogenica
Unrelated aerobic species
１
６
１
９
１
３
１
５
４
６
１
１
１
１
１
１０
１
５
１
９
１
３
１
５
４
６
０
０
０
０
０
０
０
１
０
０
０
０
０
０
０
０
１
１
１
１
１
１０
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useful to confirm the results obtained by traditional
biochemical tests. The diagnostic potentials of the PCR
developed in this study are expected to be increased
by simultaneous use with species-specific primer sets
such as B. fragilis-specific primers designed from glnA
(5) or nanH (6, 7).
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